Efficacy and Safety of Memantine and Sodium Oligomannate in Patients With Moderate to Severe Alzheimer's Disease

NCT05430867 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Treatment
Efficacy
Safety
Alzheimer Disease

Interventions

DRUG: Memantine Oral Tablet
DRUG: GV-971 capsule

Sponsor

First Affiliated Hospital Xi'an Jiaotong University